Alexion Pharma Nordics AB
556839-1022ActivePioneering transformative medicines for the global rare disease community.
Pharmaceutical Companyalexion.com
Oversigt
- 10–19
- Medarbejdere
- 50–100mio SEK
- Omsætning
- 2011
- Grundlagt
Nøglebeslutningstagere
Marc Dunoyer
Chief Executive Officer
Scott Weintraub
SVP, United States Business, Alexion
Shane Doyle
SVP, Head of Operations
Soraya Bekkali
SVP, EUCAN and International Business
+14 flere kontakter i Funnelfeedr
Beskrivelse
Alexion, operating as AstraZeneca Rare Disease, is fundamentally dedicated to pioneering new possibilities for the global rare disease community. Their core mission revolves around transforming the lives of people affected by rare conditions through the development of transformative treatments and m...
ASTRAZENECA AS